10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
Governor Newsom proposes new plan for San Joaquin River Delta - Governor Gavin Newsom revealed a n...
Read More >
On September 3, 2020, the U.S. Department of Justice’s (DOJ) Antitrust Division released a revised ...
Read More >
In preparation for a webinar I gave this week with my colleague Chris Engler, I took a deeper dive ...
Read More >
I recently talked to a group of managers about misusing Standard Operating Procedures (SOPs) and the...
Read More >
In a separate post, we discussed several cases decided by the National Labor Relations Board (NLRB) ...
Read More >
On June 7, 2019, the Office of Environmental Health Hazard Assessment (OEHHA) announced that it has ...
Read More >